- Home
- BNTX vs VLTO Comparison
BNTX vs VLTO Comparison
Compare BNTX & VLTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNTX
- VLTO
- Stock Information
- Founded
- BNTX 2008
- VLTO 2023
- Country
- BNTX Germany
- VLTO United States
- Employees
- BNTX N/A
- VLTO 17000
- Industry
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- VLTO Electrical Products
- Sector
- BNTX Health Care
- VLTO Industrials
- Exchange
- BNTX Nasdaq
- VLTO Nasdaq
- Market Cap
- BNTX 25.0B
- VLTO 25.1B
- IPO Year
- BNTX 2019
- VLTO N/A
- Fundamental
- Price
- BNTX $109.95
- VLTO $103.75
- Analyst Decision
- BNTX Strong Buy
- VLTO Buy
- Analyst Count
- BNTX 18
- VLTO 10
- Target Price
- BNTX $141.55
- VLTO $110.10
- AVG Volume (30 Days)
- BNTX 771.1K
- VLTO 1.2M
- Earning Date
- BNTX 08-04-2025
- VLTO 07-24-2025
- Dividend Yield
- BNTX N/A
- VLTO 0.42%
- EPS Growth
- BNTX N/A
- VLTO 8.36
- EPS
- BNTX N/A
- VLTO 3.50
- Revenue
- BNTX $2,968,331,171.00
- VLTO $5,279,000,000.00
- Revenue This Year
- BNTX N/A
- VLTO $6.10
- Revenue Next Year
- BNTX $10.68
- VLTO $4.70
- P/E Ratio
- BNTX N/A
- VLTO $29.65
- Revenue Growth
- BNTX 0.61
- VLTO 4.70
- 52 Week Low
- BNTX $76.53
- VLTO $83.87
- 52 Week High
- BNTX $131.49
- VLTO $115.00
- Technical
- Relative Strength Index (RSI)
- BNTX 57.74
- VLTO 68.84
- Support Level
- BNTX $105.35
- VLTO $96.46
- Resistance Level
- BNTX $109.68
- VLTO $101.91
- Average True Range (ATR)
- BNTX 2.56
- VLTO 1.60
- MACD
- BNTX 0.05
- VLTO 0.47
- Stochastic Oscillator
- BNTX 87.00
- VLTO 97.59
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.
About VLTO Veralto Corp
Veralto is a diversified industrial firm organized into two segments, water quality as well as product quality and innovation. The water quality segment offers water analytics and water treatment solutions, while the product quality and innovation segment offers coding, packaging, and color solutions for consumer packaged goods and pharmaceuticals. Headquartered in Waltham, Massachusetts, the company has around 17,000 employees. Veralto generated approximately $5.2 billion in revenue in 2024.